Results

Total Results: 884 records

Showing results for "end stage renal".

  1. digital.ahrq.gov/sites/default/files/docs/publication/2014-jason-data-for-individual-health.pdf
    January 01, 2014 - Any device falling short of this end-to-end requirement lacks a fully scientific basis as reproducibility … PIECES system is: “55 year old male Caucasian with a history of diabetes mel­ litus and chronic renal … All that is required is a web server front end and a database back-end to translate from the proprietary
  2. www.uspreventiveservicestaskforce.org/home/getfilebytoken/Rm4E5SooP2GnqJ_HVRA5M4
    January 01, 2017 - All individual studies reported end-point AHI values of 10 or less for CPAP-treated groups, and most … end-point ESS score for the 23 trials was <8). … b Two-stage process using MVAP for everyone and then home testing to determine AHI for those with an … surgery of the soft palate in the treatment of mild obstructive sleep apnea is not effective as a single-stageRenal sympathetic denervation in patients with treatment-resistant hypertension (the Symplicity HTN-2
  3. www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/carotid-artery-stenosis-screening-july-2014
    July 08, 2014 - A high comorbid condition level was defined as any end-stage disease, severe disability, or 3 or more … nonfatal MI, permanent cranial nerve damage, pulmonary embolism, pneumonia, wound infection, acute renal
  4. effectivehealthcare.ahrq.gov/sites/default/files/ch-7-user-guide-to-ocer_130129.pdf
    March 29, 2012 - due to concerns regarding drug-drug interactions or metabolic problems.8 For example, patients with end-stagerenal disease are less likely to receive medications for secondary prevention after myocardial infarction
  5. Paul Tedrick (doc file)

    www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/hais/cauti-tools/archived-webinars/mindfulness-transcript.doc
    June 10, 2014 - And we know that in the vast majority of cases, it’s the antibiotic exposure that sets the stage for … routinely meeting with our hospitalists to talk about anticoagulation dosing, dosing of antibiotics in renal … At the end of today’s call if you could all take a moment to fill out an evaluation of today’s webinar
  6. www.ahrq.gov/sites/default/files/2024-09/hanchate-report.pdf
    January 01, 2024 - included (thereby excluding a small number of CABGs performed on younger patients with disability or End-StageRenal Disease).
  7. www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-screening-for-multifactorial-dyslipidemia/lipid-disorders-in-children-screening-july-2016
    August 09, 2016 - Familial hypercholesterolemia and other monogenic conditions were excluded from this review, as were renal … Sexual maturation was evaluated at every visit through year 5 or until the participant reached Tanner stage … At the end of the study, 283 participants (3.1%) had died.
  8. integrationacademy.ahrq.gov/sites/default/files/2021-04/Table_of_Opioid_and_Pain_Management_Tools_and_Resources.pdf
    January 01, 2021 - Stewardship and Safety in the ESRD Population Conference presentation discusses opioids in the end-stagerenal disease (ESRD).
  9. digital.ahrq.gov/sites/default/files/docs/page/CongressionalBudgetOffice.pdf
    January 01, 2009 - ate cost savings for the federal government because of the costs of the subsidies: Payments would end … providers, insurers, and patients, is especially difficult because health IT networks are in an early stage … At this stage, empirical research has shown that the use of health IT in general and CDS features in … monary disease, heart disease, diabetes, coronary artery disease, chronic heart failure, chronic renal … “Effects of Multi- disciplinary Case Management in Patients with Chronic Renal Insufficiency.”
  10. www.ahrq.gov/hai/cauti-tools/archived-webinars/mindfulness-transcript.html
    December 01, 2017 - And we know that in the vast majority of cases, it's the antibiotic exposure that sets the stage for … routinely meeting with our hospitalists to talk about anticoagulation dosing, dosing of antibiotics in renal … At the end of today's call if you could all take a moment to fill out an evaluation of today's webinar
  11. effectivehealthcare.ahrq.gov/sites/default/files/01_arthritis_potential_high_impact_2012-12-10.pdf
    January 01, 2012 - scores (IKDC form, EQ VAS quality of life score) were reported between the baseline evaluation, the end … Barr virus-associated posttransplant lymphoproliferative disorder was observed in patients who had renal
  12. www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/prevention-of-opioid-user-disorder-ehc-tech-brief.pdf
    May 14, 2021 - identifying evidence, the EPC consulted a panel of Key Informants who represent subject experts and end-users … Therefore, in the end, the study questions, design, methodological approaches, and conclusions do not … Because of their role as end users, individuals with potential conflicts may be retained. … The Helping to End Addiction Long-Term Initiative. https://heal.nih.gov/. … Analgesic administration for patients with renal colic in the emergency department before and after
  13. effectivehealthcare.ahrq.gov/sites/default/files/pdf/ongoing-studies-evidence_research.pdf
    December 01, 2010 - to suggest factors that might predict relevance and utility of the completed study and associated end-products … when compared to the trial registration, and only 45 percent of studies were registered before the end … While many of these registries are no longer in existence, they likely set the stage for current clinical … Additionally, the time frame 20 examined in this project is at an early stage when trial registration … Type II Diabetes and the Metabolic Syndrome and on Inflammatory Bowel Disease, Rheumatoid Arthritis, Renal
  14. www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/statin-use-in-adults-preventive-medication
    August 23, 2022 - Asselbergs FW, Diercks GF, Hillege HL, et al; Prevention of Renal and Vascular Endstage Disease Intervention … Efficacy and safety of atorvastatin in the prevention of cardiovascular end points in subjects with type … : 26 a Daily aspirin use: 17 ALLHAT-LLT    Furberg et al, 2002 18    (Fair) Aged ≥55 y with stage … Evaluation of Rosuvastatin; MI, myocardial infarction; NR, not reported; PREVEND-IT, Prevention of Renal
  15. www.ahrq.gov/sites/default/files/wysiwyg/data/SyH-DR-Sampling-Weighting-Synthetization-Methodologies.pdf
    December 01, 2023 - For Medicare, the coverage qualification reasons were “End-stage renal disease (ESRD),” “Disability … Discharge Status The discharge status describes the status of the person as of the service end date
  16. effectivehealthcare.ahrq.gov/sites/default/files/related_files/rapid-response-chemotherapy-dental.pdf
    July 01, 2023 - oral or dental examination performed on an inpatient basis as part of comprehensive workup prior to renal … the body’s immune system, leading to impairment of resistance to infections and other disorders.7 Renal … reviewer was unsure regarding the appropriate disposition of a study (either at the abstract or full-text stage … Response, a thorough search of the MEDLINE database compiled all relevant published studies through the end … Evidence-based Practice Center (EPC) Program using streamlined literature review methods to assist end-users
  17. effectivehealthcare.ahrq.gov/sites/default/files/pdf/continuous-outcomes-quantitative-synthesis_methods.pdf
    March 01, 2011 - The summary of final key points and recommendations are presented in Table 2 at the end of this chapter … The two end points of IQR and range are not symmetric around median (or mean) if the distribution of … Allowing for uncertainty due to missing data in meta- analysis--part 1: two-stage methods. … alter the conclusions of a meta-analysis with continuous outcomes: a case study of changes in renal … monotherapy and combination therapy with inhibitors of the renin angiotensin system on proteinuria in renal
  18. effectivehealthcare.ahrq.gov/sites/default/files/pdf/adhd-heart-disease-children_research.pdf
    January 01, 2023 - other than non-melanoma skin cancer), HIV infection, organ transplant, liver failure or hepatic coma, end-stagerenal disease, respiratory failure, or severe congestive heart failure. … included to reduce the potential for misclassification and referred to the first 30 days after the end … The former use category began after indeterminate use ended (i.e., at 31 days after end of current use … of insurance coverage/pharmacy benefit, day before 65th birthday, or end of study period (December
  19. 8 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-harms_methods.pdf
    November 01, 2008 - outcomes data, including data that showed no difference in gastrointestinal adverse events at the end … Development of instruments for assessing risk of bias specifically in studies of harms is still in an early stage … Adverse Effects of Cyclooxygenase 2 Inhibitors on Renal and Arrhythmia Events: Meta-analysis of
  20. 8 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/methodsguide_chou_assessing_harms_when_comparing.pdf
    November 01, 2008 - outcomes data, including data that showed no difference in gastrointestinal adverse events at the end … Development of instruments for assessing risk of bias specifically in studies of harms is still in an early stage … Adverse Effects of Cyclooxygenase 2 Inhibitors on Renal and Arrhythmia Events: Meta-analysis of